Reglisam (Tablets, Granules) Instructions for Use

ATC Code

R07AX (Other drugs for the treatment of respiratory diseases)

Active Substance

Ammonium glycyrrhizate (Ph.Eur. European Pharmacopoeia)

Clinical-Pharmacological Group

Herbal preparation with expectorant and anti-inflammatory effects

Pharmacotherapeutic Group

Anti-inflammatory agent

Pharmacological Action

It has anti-inflammatory properties, stimulates the function of the adrenal cortex, and has a moderate expectorant effect.

Indications

As an expectorant for respiratory tract diseases with difficult-to-discharge sputum (including bronchial asthma); eczema, allergic dermatitis; asthenic conditions; arterial hypotension; Addison’s disease (diencephalic-pituitary forms, as monotherapy and in combination with ACTH); adrenal insufficiency (against the background of long-term corticosteroid therapy), including the prevention of withdrawal syndrome during the cessation of corticosteroid treatment or reduction of their dose (as part of complex therapy).

ICD codes

Dosage Regimen

Administer orally. The dose must be individualized based on the patient’s age, clinical indication, and the specific dosage form (tablets or granules) prescribed.

For respiratory conditions with difficult sputum expectoration, including bronchial asthma, take as an expectorant.

For dermatological conditions such as eczema and allergic dermatitis, use for its anti-inflammatory properties.

In cases of arterial hypotension, asthenic conditions, and Addison’s disease, administer to stimulate adrenal cortex function.

For adrenal insufficiency related to long-term corticosteroid therapy, use to prevent withdrawal syndrome during dose reduction or cessation as part of complex therapy.

Adhere strictly to the prescribed dosing schedule. Do not exceed the recommended duration of use.

Monitor for potential adverse effects, including fluid retention and allergic reactions.

In pediatric patients over 5 months, use only age-appropriate dosage forms. This product is contraindicated in children under 5 months of age.

Consult the full prescribing information for specific dosing instructions related to the chosen formulation.

Adverse Reactions

Possible retention of water in the body; allergic reactions.

Contraindications

Hypersensitivity to ammonium glycyrrhizinate, severe organic heart lesions; hepatic and/or renal failure, pregnancy, breastfeeding period, children under 5 months of age; in children over 5 months, there are contraindications for certain dosage forms.

Use in Pregnancy and Lactation

Use is contraindicated during pregnancy and breastfeeding.

Use in Hepatic Impairment

Use is contraindicated in hepatic insufficiency.

Use in Renal Impairment

Use is contraindicated in renal insufficiency.

Pediatric Use

Use is contraindicated in children under 5 months of age. In children over 5 months, it should be used in dosage forms intended for the corresponding age category.

Special Precautions

In children over 5 months, it should be used in dosage forms intended for the corresponding age category.

Drug Interactions

It is possible to enhance the effect of drugs that stimulate the function of the adrenal cortex.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.